Go Capital et al. invest €4.1m in Graftys

French GP Go Capital and Belgian investors Innovation Fund, Meusinvest and The Club Deal backed the deal.

Go Capital is investing in the business via its Ouest Ventures III fund. The vehicle closed in 2015 on €32m, according to French press reports. 

The fresh capital will support the business in the development of its activities in Belgium and the strengthening of its operations in France, with the creation of an industrialisation unit in Nantes. The business is also planning to enter new markets, including China and Japan.

Company
Graftys is a designer, manufacturer and seller of synthetic bone biomaterials. Based in Aix-en-Provence, the business was founded in 2005 by executives of the orthopaedic industry and an academic research director in the field of synthetic biomaterials, leading a research unit in Nantes.

Graftys has implemented a hybrid business model combining commercial activity and a strong R&D platform in liaison with the French academic research community. Graftys commercialises its products in more than 25 countries, including the US.

People
Go Capital – leila Nicolas (investment director).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• France
• Healthcare
• France
• Venture